Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Exp Med ; 208(9): 1889-900, 2011 Aug 29.
Article in English | MEDLINE | ID: mdl-21825016

ABSTRACT

Nuclear factor (NF)-κB, activated by IκB kinase (IKK), is a key regulator of inflammation, innate immunity, and tissue integrity. NF-κB and one of its main activators and transcriptional targets, tumor necrosis factor (TNF), are up-regulated in many inflammatory diseases that are accompanied by tissue destruction. The etiology of many inflammatory diseases is poorly understood, but often depends on genetic factors and environmental triggers that affect NF-κB and related pathways. It is unknown, however, whether persistent NF-κB activation is sufficient for driving symptomatic chronic inflammation and tissue damage. To address this question, we generated IKKß(EE)(IEC) mice, which express a constitutively active form of IKKß in intestinal epithelial cell (IECs). IKKß(EE)(IEC) mice exhibit NF-κB activation in IECs and express copious amounts of inflammatory chemokines, but only small amounts of TNF. Although IKKß(EE)(IEC) mice exhibit inflammatory cell infiltration in the lamina propria (LP) of their small intestine, they do not manifest tissue damage. Yet, upon challenge with relatively mild immune and microbial stimuli, IKKß(EE)(IEC) mice succumb to destructive acute inflammation accompanied by enterocyte apoptosis, intestinal barrier disruption, and bacterial translocation. Inflammation is driven by massive TNF production, which requires additional activation of p38 and extracellular-signal-regulated kinase mitogen-activated protein kinases (MAPKs).


Subject(s)
Intestinal Mucosa/immunology , MAP Kinase Signaling System/immunology , Mitogen-Activated Protein Kinase Kinases/immunology , NF-kappa B/immunology , Animals , Cytokines/biosynthesis , Cytokines/genetics , Cytokines/immunology , Enzyme Activation/genetics , Enzyme Activation/immunology , Gene Expression/genetics , Gene Expression/immunology , I-kappa B Kinase/genetics , I-kappa B Kinase/immunology , I-kappa B Kinase/metabolism , Inflammation/genetics , Inflammation/immunology , Inflammation/metabolism , Intestinal Mucosa/metabolism , MAP Kinase Signaling System/genetics , Mice , Mice, Knockout , Mitogen-Activated Protein Kinase Kinases/genetics , Mitogen-Activated Protein Kinase Kinases/metabolism , NF-kappa B/genetics , NF-kappa B/metabolism
2.
Immunol Lett ; 125(2): 114-8, 2009 Aug 15.
Article in English | MEDLINE | ID: mdl-19555720

ABSTRACT

Dendritic cells (DCs) differentiated in the presence of IL-10 preferentially induce regulatory T-cells and tolerance. Whether the tolerogenic properties displayed by these DCs (Tol-DCs) can be overcome has not been fully explored. Here we show for the first time that Tol-DCs express higher levels of TLR5 mRNA, but not TLR4 or TLR9 mRNA relative to DCs differentiated with GM-CSF and IL-4 (BM-DCs). In response to flagellin, a natural TLR-5 ligand, Tol-DCs produced IL-12 but not IL-10. Unlike Tol-DCs stimulated with LPS, which produce high levels of IL-10 and fail to generate a cognate inflammatory response in CD4(+) T-cells, flagellin-stimulated Tol-DCs promoted the differentiation of CD4(+) T cells with a T-helper 1 phenotype. The divergent T-cell outcomes induced by Tol-DCs in response to different TLR-ligands highlights not only their plasticity, but also points to TLR5 ligation as a potential strategy to overcome tolerance in environments that are otherwise conducive to immune unresponsiveness.


Subject(s)
Antigen Presentation , Dendritic Cells/immunology , Interferon-gamma/metabolism , Interleukin-12/metabolism , Th1 Cells/metabolism , Toll-Like Receptor 5/metabolism , Animals , Antigen Presentation/drug effects , Bone Marrow Cells/immunology , Cell Differentiation/drug effects , Cell Differentiation/immunology , Dendritic Cells/drug effects , Dendritic Cells/metabolism , Flagellin/pharmacology , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Interleukin-10/metabolism , Interleukin-4/metabolism , Lymphocyte Activation/drug effects , Male , Mice , Mice, Inbred BALB C , Mice, Transgenic , Protein Binding , Receptors, Antigen, T-Cell , Th1 Cells/immunology , Th1 Cells/pathology , Toll-Like Receptor 5/genetics , Toll-Like Receptor 5/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...